- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome
Total 7121 results
-
National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
TJ Biopharma Co., Ltd.CompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndromes(MDS)China
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
Nkarta Inc.Active, not recruitingMDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLymphoma | Myelodysplastic Syndromes | Myeloproliferative Disorders | Myeloma | Leukemia, LymphocyticUnited States
-
Baylor Research InstituteCompletedMyelodysplastic Syndromes | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFLT3 Gene Mutation Negative | FLT3 Internal Tandem Duplication Positive | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic...United States
-
Robert LowskyNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Myeloproliferative Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Adult Acute Myeloid Leukemia | de Novo Myelodysplastic SyndromesUnited States
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramRecruitingLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Acute Leukemia | Myeloproliferative Neoplasm | Pro-Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 10-19 Percent of Bone Marrow Nucleated Cells and other conditionsUnited States
-
TakedaCompletedNeoplasms | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Renal Insufficiency | Leukemia, Myelomonocytic, Chronic | Liver DiseaseUnited States, Spain
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Central Hospital, Nancy, FranceInserm U954 - N-GERE (Nutrition, Genetics and Exposition to Environmental...UnknownHigh-risk Myelodysplastic Syndromes With Excess BlastsFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Stanford UniversityCompletedB-cell Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Myeloproliferative Disorder | T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Myeloid MalignanciesUnited States
-
Epizyme, Inc.CelgeneCompletedAcute Myeloid Leukemia | Myeloproliferative Disorders | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States, Germany, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Hackensack Meridian HealthTerminatedAcute Myeloid Leukemia and Myelodysplastic SyndromeUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Precancerous/Nonmalignant Condition | Secondary Myelofibrosis | Multiple Myeloma and Malignant Plasma Cell NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Faron Pharmaceuticals LtdRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Relapsed/Refractory AMLUnited States, Finland
-
Hangzhou GluBio Pharmaceutical Co., Ltd.Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloid MalignancyChina
-
University of California, San FranciscoJohns Hopkins All Children's HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia | Chronic Myelogenous Leukemia | Biphenotypic Leukemia | Pre-leukemic Syndromes | Monosomy 7 | Bone Marrow Clonal MalformationsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host...United States
-
Shandong Provincial HospitalUnknownMyelodysplastic Syndromes,Acute Myeloid LeukemiaChina
-
Case Comprehensive Cancer CenterCompletedMyelodysplastic Syndromes | Thrombocytopenia | Chronic Myelomonocytic Leukemia | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed SideroblastsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin's Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloproliferative Disorder | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML)United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome | ThalassemiaRussian Federation
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedMyelodysplastic Syndromes | HemosiderosisItaly
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
Josep Carreras Leukaemia Research InstituteCelgeneRecruitingMyelodysplastic SyndromesSpain
-
University of Erlangen-Nürnberg Medical SchoolNovartis PharmaceuticalsTerminated
-
Centre Hospitalier Universitaire, AmiensUnknownMyelodysplastic SyndromesFrance
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; YUKIGUNI COMPANYCompletedMyelodysplastic SyndromeUnited States
-
Haukeland University HospitalNot yet recruitingAcute Myeloid Leukemia, Adult | Myelodysplastic Syndromes, AdultNorway
-
Indiana University School of MedicineTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Lymphoid | Leukemia, Myelogenous, ChronicUnited States